Lv1
30 积分 2024-10-02 加入
Adjuvant Immunotherapy Does Not Improve Survival in Non-small Cell Lung Cancer with Major/Complete Pathological Response after Induction Immunotherapy
1天前
待确认
183 Radical dose re-irradiation in patients with in-field thoracic tumour recurrence at the Northern Ireland Cancer Centre (NICC)- single centre experience
1天前
已完结
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial
3个月前
已完结
A prospective study of neoadjuvant pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma: The Keystone-001 trial
3个月前
已完结
Risk factors for recurrence in patients with resected N1 non-small cell lung cancer - a systematic review and meta-analysis
3个月前
已完结
[The effect of tumor spread through air spaces on the prognosis of patients with stage Ⅰ non-small cell lung cancer: a meta-analysis]
3个月前
已完结
Disease recurrence after resection for stage I lung cancer
4个月前
已完结
Long-term outcomes of 5-year survivors without recurrence after the complete resection of non-small cell lung cancer after lobectomy: a landmark analysis in consideration of competing risks
4个月前
已完结
IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer
7个月前
已完结
First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
7个月前
已完结
皖公网安备34019202002308
